Mostrando 10 resultados de: 15
Filtros aplicados
Publisher
2007 NSTI Nanotechnology Conference and Trade Show - NSTI Nanotech 2007, Technical Proceedings(2)
ChemMedChem(2)
ACS Applied Bio Materials(1)
ACS Biomaterials Science and Engineering(1)
ACS Nano(1)
Área temáticas
Farmacología y terapéutica(12)
Enfermedades(7)
Medicina y salud(3)
Fisiología humana(1)
Fisiología y materias afines(1)
Área de conocimiento
Nanopartícula(7)
Biomedicina(2)
Biotecnología(1)
Ciencia de materiales(1)
Nanocompuesto(1)
Objetivos de Desarrollo Sostenible
ODS 3: Salud y bienestar(15)
ODS 9: Industria, innovación e infraestructura(15)
ODS 10: Reducción de las desigualdades(13)
ODS 12: Producción y consumo responsables(2)
Origen
scopus(15)
Dual Encapsulated Dacarbazine and Zinc Phthalocyanine Polymeric Nanoparticle for Photodynamic Therapy of Melanoma
ArticleAbstract: Purpose: Melanoma is an invasive and very aggressive skin cancer due to its multi-drug resistance thPalabras claves:dacarbazine, Drug resistance, melanoma, Nanoparticle, Photodynamic TherapyAutores:da Silva de Barros A.O., de Oliveira Siqueira L.B., do Reis S.R.R., Frank Alexis, Helal-Neto E., Pinto S.R., Portilho F.L., Rebelo Alencar L.M., Ricci-Junior E., Santos-Oliveira R., Si Amar DahoumaneFuentes:scopusGraphene quantum dots decorated with imatinib for leukemia treatment
ArticleAbstract: The use of graphene quantum dots as biomedical device and drug delivery system has been increasing.Palabras claves:Biomedical device, drug delivery, Graphene quantum dot, Nanoparticle, Smart materialAutores:Aguiar L., Duarte de Menezes F., Felix D.M., Frank Alexis, Gemini-Piperni S., Junior S.A., Liu Y., Midlej V.d.V.P., Rebelo Alencar L.M., Ricci-Junior E., Santos-Oliveira R., Zhang J., Zhu L.Fuentes:scopusHER-2-targeted nanoparticle-affibody bioconjugates for cancer therapy
ArticleAbstract: (Figure Presented) Affibodies are a class of polypeptide ligand that are potential candidates for tiPalabras claves:Affibodies, Antitumor agents, Nanoparticles, PLA-PEG copolymers, Targeted therapyAutores:Basto P.A., Farokhzad O.C., Frank Alexis, Levy-Nissenbaum E., Marein S.L., Molnar L.K., Pridgen E.M., Radovic-Moreno A.F., Wang A.Z., Westerhof K., Zhang L.Fuentes:scopusEngineering of targeted nanoparticles for cancer therapy using internalizing aptamers isolated by cell-uptake selection
ArticleAbstract: Figure Persented: One of the major challenges in the development of targeted nanoparticles (NPs) forPalabras claves:aptamer, in vitro selection, Internalization, Nanoparticles, targeted cancer therapyAutores:Chan J.M., Cheng J., Digga E., Farokhzad O.C., Frank Alexis, Langer R.S., Levy-Nissenbaum E., Lupták A., Shi J., Teply B.A., Xiao Z.Fuentes:scopusStrategies for High Grafting Efficiency of Functional Ligands to Lipid Nanoemulsions for RGD-Mediated Targeting of Tumor Cells in Vitro
ArticleAbstract: Lipid nanoemulsions (LNEs) are promising nanocarriers for delivering high payloads of lipophilic molPalabras claves:active targeting, Cáncer, grafting efficiency, nanoparticles, lipid nanoemulsions, RGD peptideAutores:Akasov R., Attia M.F., Frank Alexis, Swasy M.I., Whitehead D.C.Fuentes:scopusSuperparamagnetic iron oxide nanoparticle-aptamer bioconjugates for combined prostate cancer imaging and therapy
ArticleAbstract: (Chemical Equation Presented) Multifunctional superparamagnetic iron oxide nanoparticles: Herein wePalabras claves:doxorubicin, Nanoparticles, Superparamagnetic, TCL-SPIONAutores:Bagalkot V., Bander N.H., Cima M.J., Farokhzad O.C., Frank Alexis, Gu F.X., Jon S., Kantoff P.W., Langer R.S., Shaikh M., Vasilliou C.C., Wang A.Z., Yuet K., Zhang L.Fuentes:scopusTargeted aptamer-nanoparticles to diminish drug resistance of cancer cells in vitro study
Conference ObjectAbstract: Using prostate cancer as a model, we report the drug release of Docetaxel and doxorubicin from aptamPalabras claves:aptamer, doxorubicin, Poly (D,L-lactic-co-glycolic acid) (PLGA), Prostate cancer, Targeted deliveryAutores:Basto P.A., Farokhzad O.C., Frank Alexis, Langer R.S., Zhang L.Fuentes:scopusTargeted nanoparticle-polypeptide bioconjugates for breast cancer therapy
Conference ObjectAbstract: Novel approaches that allow for a more effective and less toxic chemotherapy for disseminated breastPalabras claves:Docetaxel, HER2, Pla, Poly (lactic acid), Targeted nanoparticlesAutores:Basto P.A., Farokhzad O.C., Frank Alexis, Gu F.X., Langer R.S., Levy-Nissenbaum E., Radovic-Moreno A.F.Fuentes:scopusTargeted nanoparticles for cancer therapy
ArticleAbstract: Over the past decade, there has been an increasing interest in using nanotechnology for cancer theraPalabras claves:Autores:Farokhzad O.C., Frank Alexis, Gu F.X., Hong S., Karnik R., Langer R.S., Levy-Nissenbaum E., Wang A.Z.Fuentes:scopusNano-polypharmacy to treat tumors: Coencapsulation of drug combinations using nanoparticle technology
OtherAbstract:Palabras claves:Autores:Frank AlexisFuentes:scopus